International Biotechnology Trust offers investors access to the fast growing biotechnology sector through an actively managed, diversified fund. Its award winning fund managers at SV Health Investors are scientifically and medically trained with over 60 years of experience in this specialist sector between them. As well as investing in a wide ranging portfolio of global quoted biotechnology stocks, we include a small proportion of otherwise inaccessible carefully selected unquoted investments which have the potential to deliver additional returns over the long term. Excellent management teams, unique innovative products and strong potential for outperformance are the key criteria for inclusion in our diversified portfolio of assets.
International Biotechnology Trust introduction video – 00:22
Dr Carl Harald Janson, Lead Investment Manager introduction – 03:07
Performance 1, 3 & 5 years – 3:47
Dividend – 05:06
Share price/discount – 05:42
Dividend sustainability – 06:34
Biotech is a high growth sector – 07:25
Favourable regulatory environment – 10:45
Worldwide pharma sales – 11:15
M&A – 11:37
Risks – 13:15
The US market – 14:11
Sector valuation – 16:13
IBT investment process – 17:04
Risk mitigation – 17:54
Portfolio breakdown – 19:42
Oncology treatment options – 21:54
Top 10 holdings – 23:14
Unqouted portfolio – 24:00
Awards & Summary -25:58
Q&A -25:19
PIWORLD provides investors with the latest news and insight to listed companies and their management teams through either live or recorded results presentations, corporate overviews, management interviews and Capital Market Days. Together with interviews from leading fund managers, market specialists and esteemed private investors, we aim to keep the private investor community up to date and informed.
PIWORLD delivers high quality audio and video content to present anything from full-year and interim results to Capital Markets Days and corporate overviews. We bridge the gap between listed companies and the private investor community, who drive the share price and provide liquidity, providing a time and cost effective medium to reach this diverse and important audience.
